By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Life Care NewsLife Care NewsLife Care News
  • Home
  • Business
    • Business
  • News
  • Tech
  • Entertainment
  • Health
  • Education
  • Automobile
  • Sports
Search
Technology
  • Advertise
  • Advertise
Health
Entertainment
  • Home
  • Business
    • Business
  • News
  • Tech
  • Entertainment
  • Health
  • Education
  • Automobile
  • Sports
  • Advertise
  • Advertise
Copyright © 2015 - 2024 LifeCareNews Network. All Rights Reserved.
LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Reading: Cross Medical Group Introduces HydraFacial Treatments for Advanced Skin Rejuvenation
Share
Notification Show More
Font ResizerAa
Life Care NewsLife Care News
Font ResizerAa
  • Education
  • Automobile
  • Entertainment
  • News
  • Tech
  • Sports
Search
  • Home
  • Home
    • Home 1
    • Default Home 5
  • Categories
  • Categories
    • Tech
    • Entertainment
    • Automobile
    • Sports
    • Education
    • News
    • Health
  • Bookmarks
  • Bookmarks
  • More Foxiz
    • Sitemap
  • More Foxiz
    • Sitemap
Follow US
  • Advertise
  • Advertise
Copyright © 2015 - 2024 LifeCareNews Network. All Rights Reserved. LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Health

Cross Medical Group Introduces HydraFacial Treatments for Advanced Skin Rejuvenation

GlobeNews Wire
Last updated: 25/05/2025 10:52 PM
GlobeNews Wire
Share
3 Min Read
Cross Medical Group Introduces HydraFacial Treatments for Advanced Skin Rejuvenation
SHARE
Cross Medical Group Introduces HydraFacial Treatments for Advanced Skin Rejuvenation

PHILADELPHIA and VILLANOVA, Pa., May 23, 2025 (GLOBE NEWSWIRE) — Cross Medical Group is pleased to announce that HydraFacial treatments are now available at the practice. A HydraFacial at their Philadelphia and Villanova offices, which is sometimes referred to as “hydradermabrasion,” is an advanced skin resurfacing treatment that provides a renewed glow to your complexion through a combination of deep cleansing, exfoliation, extraction, and hydration, along with the infusion of customized serums that are designed to deeply nourish the skin. This non-invasive, medical-grade skin treatment improves many common skincare concerns with no side effects and little to no downtime.

Environmental or lifestyle factors can result in the accumulation of dead skin cells, causing your skin to appear dull, lifeless, or flaky when not removed effectively. Moreover, as your skin ages, it becomes thinner, and accumulated sun damage over the years can contribute to a loss of radiance. A HydraFacial can be ideal for removing the dead skin, debris, and oils that can build up on the outer surface of the skin. There are three main steps involved: cleansing, extraction, and hydration. In addition to removing dirt and impurities, HydraFacials also help to boost circulation.

HydraFacial patients may notice brighter and smoother skin with fewer acne breakouts after the procedure, and these results can last for up to one month or more. This gentle, highly versatile, and well-tolerated facial rejuvenation treatment is beneficial for patients of all ages, skin types, and skin tones, at any time of the year. The serums that are infused into the pores during a HydraFacial are tailored to address the specific needs of each patient. They provide plumper, deeply hydrated, and nourished skin.

Cross Medical Group also offers many surgical cosmetic treatments for the face, breast, and body, along with other non-surgical treatments including minimally invasive injectables, skin rejuvenation and resurfacing options, lasers and lights, and body contouring procedures at their offices in Philadelphia and Villanova. Their team is committed to the utmost safety and high-quality results.

For more information about HydraFacials, contact Cross Medical Group. Call their office in Philadelphia (215) 561-9100 or Main Line’s Villanova (610) 688-9100. You can also send a message online to request a consultation.

You Might Also Like

Richmind Announces Entry Into Premium Real Estate Development in the UAE

Teva Presents Latest Schizophrenia Portfolio Data Including Real-World Outcomes with UZEDY (risperidone) Showing Lower Rates of and Longer Time to Relapse Compared to Oral Treatment Options and New Phase 3 SOLARIS Data Showing No Incidence of PDSS with TE

Spirit Blockchain Capital and Astralane Unveil Strategic Partnership to Launch Staked SOL Index, Expanding Multi-Chain Treasury Management Solutions

Securities Fraud Investigation Into Ready Capital Corporation (RC) Announced Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

Chromafora Receives Frost & Sullivan’s 2025 Global New Product Innovation Award for Excellence in PFAS Water Treatment Solutions

TAGGED:advancedagesannounceavailablecleansingcrossdeaddeeplyextractionglobegrouphydradermabrasionhydrafacialhydrationmaymedicalnewswireofficespatientsphiladelphiapleasedpracticereferredremovingserumsskinsometimestreatmenttreatmentsvillanova

Sign Up For Daily Newsletter

Be keep up! Get the latest breaking news delivered straight to your inbox.

By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
Share This Article
Facebook Twitter Copy Link Print
Share
Previous Article MediPharm Labs Cautions Shareholders about Dissident Nominees Governance Failures at Check-Cap Ltd. MediPharm Labs Cautions Shareholders about Dissident Nominees Governance Failures at Check-Cap Ltd.
Next Article Tevogen Bio Plans to Expand Specialty Care Pipeline to Include Patients 65+, Building on Previous Forecast of Nearly  Billion in Launch-Year; Updated rNPV to Follow Tevogen Bio Plans to Expand Specialty Care Pipeline to Include Patients 65+, Building on Previous Forecast of Nearly $1 Billion in Launch-Year; Updated rNPV to Follow

Stay Connected

FacebookLike
TwitterFollow
PinterestPin
InstagramFollow
YoutubeSubscribe
Google NewsFollow
LinkedInFollow
MediumFollow
- Advertisement -

Latest News

Lipella Pharmaceuticals Issues Letter from the CEO to Stockholders Following Nasdaq Delisting
Lipella Pharmaceuticals Issues Letter from the CEO to Stockholders Following Nasdaq Delisting
Health 26/06/2025
MEME COINS INC., a Controlled Subsidiary of DOGP, to Acquire 2 Billion DOG Tokens from Tipestry
MEME COINS INC., a Controlled Subsidiary of DOGP, to Acquire 2 Billion DOG Tokens from Tipestry
Health 26/06/2025
Bondholders approve amended terms of the 2025 and 2028 convertible bonds
Bondholders approve amended terms of the 2025 and 2028 convertible bonds
Health 26/06/2025
Gold H2 Delivers First Successful Subsurface Bio-Stimulated Hydrogen Production Field Trial
Gold H2 Delivers First Successful Subsurface Bio-Stimulated Hydrogen Production Field Trial
Health 26/06/2025
//

We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.

Quick Link

  • About Us
  • Contact Us
  • Editorial Guidelines
  • Privacy Policy
  • Terms and Conditions

Top Categories

  • Automobile
  • Education
  • Entertainment
  • Health
  • News
  • Sports
  • Tech

Sign Up for Our Newsletter

Subscribe to our newsletter to get our newest articles instantly!

Life Care NewsLife Care News
Follow US
Copyright © 2015 - 2024 LifeCareNews Network. All Rights Reserved. LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Join Us!
Subscribe to our newsletter and never miss our latest news, podcasts etc..

Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?